OOIR: Observatory of International Research

Papers

(The H4-Index of RMD Open is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Associations of infection burden with Kawasaki disease in a population-based setting during 30 years	130
Impact of Sjögren’s disease on quality of sexual life using the Qualisex score	111
Incidence of collagen-induced arthritis is elevated by a high-fat diet without influencing body weight in mice	100
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study	92
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy	76
Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up	75
Whipple’s disease: a rare cause of sacroiliitis	64
Effects of ibuprofen on gene expression in chondrocytes from patients with osteoarthritis as determined by RNA-Seq	60
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study	58
Classification of rheumatoid arthritis: is it time to revise the criteria?	53
Window of opportunity in psoriatic arthritis: the earlier the better?	53
Exploring complement biomarkers in suspected axial spondyloarthritis	52
Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study	51
Identification of variants in genes associated with autoinflammatory disorders in a cohort of patients with psoriatic arthritis	51
Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach	47
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study	47
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis	46
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis	46
Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination	45
Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort stud	44
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort	43
Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan	43
Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data	43
Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts	42
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry	42

COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2	41
Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database	39
Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases	36
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination	33
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy	33
Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study	33
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years	32
Fibromyalgia and mortality: a systematic review and meta-analysis	32